Measuring fatigue in people with multiple sclerosis – which questionnaire should be used? A Plain Language Summary of Publication

Paul Kamudoni1 Global Evidence & Value Development - R&D, Merck Healthcare KGaA, Darmstadt, Germany

Jeffrey Johns2 Institute of Medicines Development, Cardiff, UK

Karon F. Cook3 Feral Scholars, Broaddus, TX, USA

Rana Salem4 Department of Rehabilitation Medicine, University of Washington, Seattle, USA

Sam Salek2 Institute of Medicines Development, Cardiff, UK;5 School of Life & Medical Sciences, University of Hertfordshire, Hatfield, UK

Jana Raab1 Global Evidence & Value Development - R&D, Merck Healthcare KGaA, Darmstadt, Germany

Rod Middleton6 UK MS Register, Swansea University Medical School, Swansea, UK

Christian Henke1 Global Evidence & Value Development - R&D, Merck Healthcare KGaA, Darmstadt, Germany

Dagmar Amtmann4 Department of Rehabilitation Medicine, University of Washington, Seattle, USA

Your download is now in progress and you may close this window